IPO Premiums
IPO calendar
AMListed

Aakaar Medical Technologies Limited

Bookbuilding IPO · NSE

Price band
₹68 - ₹72
Lot size
1,600 shares
Issue amount
₹27 cr
Total subscription
2.25×
Current price₹67.45
Listing price ₹75
Watch live price ↗
Opens
20 Jun 2025
Closes
24 Jun 2025
Allotment
25 Jun 2025
Listing
27 Jun 2025

Offer at a glance

Issue overview

Issue size
37,50,400 shares
Face value
₹10 per share
Minimum investment
₹1,08,800
Fresh issue
₹27 cr
Offer for sale
₹0 cr
Registrar
Bigshare Services Private Limited
Listing exchange
NSE
Maximum investment
₹1,15,200
Issue type
Bookbuilding IPO
Shares before issue
1,04,22,416
Shares after issue
1,41,72,816

Lot sizes

CategoryLotsSharesAmount
RETAIL11,600₹1,15,200
HNI23,200₹2,30,400

Share reservation

QIB26.54%
HNI22.53%
RETAIL46.51%
Market Maker4.43%

Subscription & GMP

Subscription by category

Total subscribed2.25×

Missing multiples are calculated from bids and offered shares when available.

QIB3.51×
NIB1.43×
RETAIL1.93×

GMP history

00.5117 Jun: ₹019 Jun: ₹020 Jun: ₹021 Jun: ₹023 Jun: ₹024 Jun: ₹025 Jun: ₹012 Nov: ₹025 Nov: ₹0
17 Jun₹025 Nov

Application-wise demand

CategoryReserved applicationsApplied applications
QIB—7
NIB—123
RETAIL—1,507

Subscription demand

Amounts in ₹ crore. HNI subcategories are included in the NII total.

CategoryOfferedDemand
QIBs5.1317.97
RETAIL8.9917.36

Financial performance

Company financials

In Crores · Reported periods may include interim results.

Revenue & profitIn Crores
020406080Mar-23 · Revenue: 32.88Mar-23 · Profit after tax: 2.15Mar-23Mar-24 · Revenue: 46.27Mar-24 · Profit after tax: 2.87Mar-24Mar-25 · Revenue: 61.76Mar-25 · Profit after tax: 6.04Mar-25
RevenueProfit after tax

Key performance indicators

MetricMar-25Mar-24Mar-23
EPS6.133.142.36
ROE000
ROCE21.0217.6822.3
RONW33.8125.8824.35
PRE IPO(PE)12.4300
POST IPO(PE)16.900

Values and labels as reported in the issue data.

Company information

Company profile

Aakaar Medical Technologies Limited, established in June 2013, is a company focused on aesthetic medical solutions, offering a wide range of specialized cosmetic products and devices. It primarily caters to dermatologists, plastic surgeons, aesthetic physicians, and cosmetologists. The company provides both its own brands—comprising products made in India and devices produced internationally—as well as imported brands from countries like South Korea, Spain, Italy, and Austria. These products are mainly supplied to professionals who either use them during treatments or sell them to end users. Aakaar’s offerings include skincare for home and professional use, injectable and contouring products, hair care solutions such as growth serums and tablets, medifacial kits, and various medical devices. These devices are used for treatments like urinary incontinence, tattoo removal, skin rejuvenation, laser hair reduction, and hair transplants. With a presence across India, the company has a strong network of 90 trained sales and service engineers, supporting a large and satisfied customer base. It distributes its products in multiple states including Delhi, Haryana, Punjab, Chandigarh, Uttarakhand, Uttar Pradesh, Bihar, West Bengal, Assam, Gujarat, Madhya Pradesh, Maharashtra, Karnataka, Telangana, and Tamil Nadu.

Strengths

  • Strong and Experienced Leadership: Managed by industry experts with deep domain knowledge in aesthetic medicine, driving strategic growth and operational excellence.
  • Diversified Product Portfolio: Offers a comprehensive range of aesthetic devices and consumables, including both in-house and imported brands, catering to varied customer needs.
  • Extensive Geographic Footprint: Maintains a robust pan-India presence through direct branches and an established consignment partner network, ensuring broad market coverage and accessibility.

Risk factors

  • High Dependence on Imported Products: Significant reliance on third-party international brands makes the company vulnerable to supply chain interruptions, import delays, and foreign market uncertainties.
  • Reliance on Contract Manufacturers: Heavy dependence on external manufacturing partners and loan license arrangements increases exposure to risks around production consistency, quality assurance, and regulatory compliance.
  • Exposure to Cost Fluctuations: Volatile prices of raw materials, utilities, and logistics may adversely affect margins, operational efficiency, and overall financial performance.

Promoters

Dilip Ramesh Meswani

Bindi Dilip Meswani

Registrar & documents

Lead manager

Indorient Financial Services Limited

Registered office

801, Heritage Plaza, Telli Galli Cross Road Andheri (East), Mumbai, Maharashtra, 400069

+91 84528 44024

[email protected]Company website ↗

Frequently Asked Questions

What is Aakaar Medical Technologies IPO GMP today?

Currently, Aakaar Medical Technologies IPO Grey Market Premium (GMP) is trading around ₹0 or awaiting active buyer-seller quotes in the grey market. The issue price is set at ₹72. Track daily updates on IPO Premiums as bidding numbers unfold.

What is the lot size and minimum investment for Aakaar Medical Technologies IPO?

The minimum bid lot size for Aakaar Medical Technologies IPO is 1,600 shares. At the cut-off price of ₹72 per share, retail investors need a minimum application amount of ₹1,15,200 per lot. Retail applicants can apply for a maximum of 1 lots (up to ₹2,00,000).

When will Aakaar Medical Technologies IPO allotment status be announced?

The allotment status for Aakaar Medical Technologies IPO is scheduled to be finalized on 25 Jun 2025. If you applied for the IPO, you can verify whether shares have been allocated to your Demat account through Bigshare Services Private Limited's official portal or via BSE/NSE allotment portals.

How can I check Aakaar Medical Technologies IPO allotment status online by PAN?

To check Aakaar Medical Technologies IPO allotment status: 1) Visit the registrar portal (Bigshare Services Private Limited) or the BSE IPO allotment page. 2) Select 'Aakaar Medical Technologies Limited' from the company dropdown. 3) Choose 'PAN' as your identification mode and enter your 10-digit Permanent Account Number. 4) Click 'Search' to view your allotted share quantity and application status.

Explore More IPO Analysis & Live Tools

Compare the price band and required investment with company financials and official offer documents. Grey market premium (GMP) figures are indicative market estimates collected from primary market brokers and do not establish the official listing price.

Regulatory Disclaimer: Grey Market Premium (GMP) is an unofficial, unregulated indicator of market sentiment and does not represent a stock exchange transaction, guarantee, or investment advice. IPO Premiums is an informational and research portal and is not a SEBI-registered investment advisor. Please consult a qualified financial advisor before applying for any IPO.
Aakaar Medical Technologies IPO GMP Today, Subscription Status & Allotment Date | IPO Premiums